OTC GLP-1 vs. prescription: what you’re actually buying. - Reddit

What are GLP-1 receptor agonists, and how do they work?

GLP-1 (glucagon-like peptide-1) is an incretin hormone secreted by intestinal L-cells in response to food intake. It acts on GLP-1 receptors in the pancreas, hypothalamus, stomach, and other tissues. Its primary actions include stimulating insulin secretion in a glucose-dependent manner, suppressing glucagon, slowing gastric emptying, and reducing appetite through central hypothalamic signaling.

Prescription GLP-1 receptor agonists—semaglutide and tirzepatide are the most widely discussed for weight management—are engineered peptide drugs that bind to and activate GLP-1 receptors with much higher potency and a much longer half-life than endogenous GLP-1. Semaglutide, for example, has a half-life of approximately one week, which is why it’s dosed once weekly by injection. Endogenous GLP-1 has a half-life of minutes.

These are complex peptide drugs, manufactured under pharmaceutical-grade conditions, requiring a valid prescription from a licensed clinician. They are not available over the counter and cannot legally be sold without a prescription.

What are “OTC GLP-1” products actually made of?

Products marketed as “OTC GLP-1,” “natural GLP-1,” “GLP-1 support,” or “GLP-1 activators” are dietary supplements. Common ingredients include:

• Berberine:A plant alkaloid with some evidence for modest blood sugar effects, marketed as a “natural Ozempic” or “nature’s GLP-1.” Berberine may have effects on insulin sensitivity through AMPK activation, but it does not activate GLP-1 receptors. The comparison is misleading.
• Soluble fiber (glucomannan, psyllium): Slows gastric emptying and may modestly increase endogenous GLP-1 secretion. The effect magnitude is far below that of prescription GLP-1 receptor agonists.
• Inulin and prebiotics: Similar modest incretin-supporting effects through gut microbiome modulation. Not a drug-class substitute.
• GLP-1 patches: Transdermal patches claiming to deliver GLP-1 support. No FDA-approved transdermal delivery system for semaglutide or tirzepatide exists. These products do not contain prescription GLP-1 drugs.

None of these products activate GLP-1 receptors the way semaglutide or tirzepatide does. The clinical trial data showing 15–22% mean weight reduction belongs to the prescription drugs, not to supplements with GLP-1 in the name.

How does an OTC supplement compare to prescription GLP-1?

Why do supplement sellers use “GLP-1” language?

Dietary supplement manufacturers are not allowed to claim their products diagnose, cure, mitigate, treat, or prevent diseases—but they can make structure/function claims (“supports healthy blood sugar already in normal range,” “supports metabolic health”) without FDA pre-market approval. The regulatory bar for supplement marketing is dramatically lower than for drug marketing.

The phrase “GLP-1 support” is a structure/function framing that evokes the prescription drug category without claiming to be it. Marketers know that consumers searching for weight management options will encounter both the supplement and the prescription drug in the same search results. The branding conflates the categories intentionally.

The FDA has issued consumer advisories clarifying that GLP-1 drugs are prescription-only and that supplements making GLP-1 claims do not contain the actual drugs. The warning is genuine.

What does the prescription path actually look like?

Getting a prescription GLP-1 for weight management through a telehealth platform does not require an in-person visit, but it does require a real clinician evaluation. Here is how the legitimate path works:

• Intake form: You complete a structured intake covering health history, current medications, weight history, goals, and relevant symptoms. This gives the clinician the information needed to evaluate you safely.
• Clinician review: A licensed clinician reviews your intake asynchronously. They assess eligibility, flag contraindications, and decide whether a GLP-1 prescription is appropriate for your situation.
• Prescription issued: If appropriate, the clinician issues a prescription to a licensed pharmacy. For compounded semaglutide or tirzepatide, that means a licensed 503A compounding pharmacy preparing the medication domestically.
• Medication delivered: The compounded injectable is shipped directly to you with instructions.
• Ongoing supervision: The clinician monitors your response, adjusts the dose through the titration schedule, and reviews any side effects or concerns.

This is what separates prescription GLP-1 therapy from a supplement. The supplement involves no clinician, no evaluation, no prescription, no pharmacy oversight, and no active drug. The prescription path involves all of these.

How does compounded GLP-1 differ from branded?

Within the prescription category, there is a distinction between branded GLP-1 products (Zepbound, Wegovy, Mounjaro, Ozempic) and compounded versions of the same active ingredients prepared by licensed 503A pharmacies.

Compounded semaglutide and tirzepatide are prescription medications requiring a valid clinician prescription and licensed pharmacy dispensing. They are not FDA-approved (no compounded drug is), but they operate within a legal compounding framework during active drug shortage periods.

PepScribe works exclusively with compounding done in the USA by licensed 503A pharmacies. No hidden overseas supply chain. The distinction between a 503A-prepared compounded prescription and a supplement sold online as “OTC GLP-1” is fundamental: one involves a clinician, a prescription, and a licensed domestic pharmacy; the other does not.

Frequently asked questions